newsfilter
← Latest News
PR Newswire·

CryoLife Receives FDA Authorization to Commence PROACT Xa Clinical Trial

CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it has received...